Harvest Portfolios Group

The reality of drug pricing; Paul MacDonald CIO interviewed by Morningstar.ca

March 1, 2019
The reality of drug pricing; Paul MacDonald CIO interviewed by Morningstar.ca

The reality of drug pricing

By Andrew Willis | 01/03/19

High drug prices have been making headlines recently, with a recent U.S. Senate hearing into the matter earlier this week.

Should investors inject their portfolios with some pharma exposure to get behind this trend? Or are there dangerous side-effects to watch out for when getting behind companies selling thousand-dollar doses?

Read the full article here:

 

What’s New
Sign up to receive our monthly updates
HHL Harvest Healthcare Leaders Income ETF
HBF Harvest Brand Leaders Plus Income ETF
HTA Harvest Tech Achievers Growth & Income ETF
HUTL Harvest Equal Weight Global Utilities Income ETF
HGR Harvest Global REIT Leaders Income ETF
HPF Harvest Energy Leaders Plus Income ETF
HUBL Harvest US Bank Leaders Income ETF
HLIF Harvest Canadian Equity Income Leaders ETF
TRVI Harvest Travel & Leisure Income ETF
HRIF Harvest Diversified Equity Income ETF
HHLE Harvest Healthcare Leaders Enhanced Income ETF
HBFE Harvest Brand Leaders Enhanced Income ETF
HTAE Harvest Tech Achievers Enhanced Income ETF
HUTE Harvest Equal Weight Global Utilities Enhanced Income ETF
HLFE Harvest Canadian Equity Enhanced Income Leaders ETF
HDIF Harvest Diversified Monthly Income ETF
HGGG Harvest Global Gold Giants Index ETF
HBLK Blockchain Technologies ETF
TRVL Harvest Travel & Leisure Index ETF
HCLN Harvest Clean Energy ETF